[go: up one dir, main page]

NO20070986L - Antiblodplate middel og fremgangsmate for fremstilling derav - Google Patents

Antiblodplate middel og fremgangsmate for fremstilling derav

Info

Publication number
NO20070986L
NO20070986L NO20070986A NO20070986A NO20070986L NO 20070986 L NO20070986 L NO 20070986L NO 20070986 A NO20070986 A NO 20070986A NO 20070986 A NO20070986 A NO 20070986A NO 20070986 L NO20070986 L NO 20070986L
Authority
NO
Norway
Prior art keywords
preparation
plate agent
antibody plate
compound
antibody
Prior art date
Application number
NO20070986A
Other languages
English (en)
Norwegian (no)
Inventor
Kenji Sakuratani
Koji Sato
Syouko Yoshida
Tsutomu Yagi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20070986L publication Critical patent/NO20070986L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
NO20070986A 2004-08-06 2007-02-21 Antiblodplate middel og fremgangsmate for fremstilling derav NO20070986L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004230011 2004-08-06
PCT/JP2005/014405 WO2006013962A1 (fr) 2004-08-06 2005-08-05 Agent antiplaquettaire et procédé servant à produire celui-ci

Publications (1)

Publication Number Publication Date
NO20070986L true NO20070986L (no) 2007-04-20

Family

ID=35787240

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070986A NO20070986L (no) 2004-08-06 2007-02-21 Antiblodplate middel og fremgangsmate for fremstilling derav

Country Status (12)

Country Link
US (1) US20090137600A1 (fr)
EP (1) EP1775293A4 (fr)
JP (1) JPWO2006013962A1 (fr)
KR (1) KR20070046099A (fr)
CN (1) CN101072769A (fr)
AU (1) AU2005268058A1 (fr)
CA (1) CA2574626A1 (fr)
IL (1) IL180988A0 (fr)
MX (1) MX2007001566A (fr)
NO (1) NO20070986L (fr)
RU (1) RU2007108297A (fr)
WO (1) WO2006013962A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102924476A (zh) * 2009-02-09 2013-02-13 沈阳药科大学 新噁嗪类化合物及其用途
CN101486714B (zh) * 2009-02-09 2013-03-20 沈阳药科大学 新噁嗪类化合物及其抗血小板聚集的用途
CN101486713B (zh) * 2009-02-09 2013-05-15 沈阳药科大学 呋喃并[2,3-h]色烯类化合物及其抗血小板聚集的用途
MX2011011510A (es) 2009-04-27 2011-11-18 Dow Agrosciences Llc Compuestos insecticidas de piridina.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
JP3994453B2 (ja) * 1995-10-13 2007-10-17 日産化学工業株式会社 ピラゾロン類
WO2004002409A2 (fr) * 2002-06-27 2004-01-08 Nitromed, Inc. Inhibiteurs selectifs de la cyclooxygenase 2, compositions associees et methodes d'utilisation
KR20050083761A (ko) * 2002-12-02 2005-08-26 후지사와 야꾸힝 고교 가부시키가이샤 Ｃｏｘ－ｉ저해제로서 유용한 피라졸 유도체
EP1591443B1 (fr) * 2003-02-07 2010-08-25 Daiichi Sankyo Company, Limited Derive de pyrazole
WO2004094407A1 (fr) * 2003-04-21 2004-11-04 Daiichi Pharmaceutical Co. Ltd. Derive heterocyclique a cinq chainons

Also Published As

Publication number Publication date
RU2007108297A (ru) 2008-09-20
IL180988A0 (en) 2007-07-04
EP1775293A1 (fr) 2007-04-18
KR20070046099A (ko) 2007-05-02
WO2006013962A1 (fr) 2006-02-09
EP1775293A4 (fr) 2009-09-16
US20090137600A1 (en) 2009-05-28
CN101072769A (zh) 2007-11-14
JPWO2006013962A1 (ja) 2008-05-01
AU2005268058A1 (en) 2006-02-09
CA2574626A1 (fr) 2006-02-09
MX2007001566A (es) 2007-04-16

Similar Documents

Publication Publication Date Title
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
AR061980A1 (es) Acilanilidas sustituidas y metodos para su utilizacion
EA200601584A1 (ru) Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
NO20075624L (no) Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
NO20080761L (no) Acykliske Ikur inhibitorer
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
UA87153C2 (ru) Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы
UA107175C2 (uk) Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
NO20073404L (no) Kaliumsalt av en HIV-integraseinhibitor
WO2005074603A3 (fr) Utilisation d'aminobenzoxazoles comme agents therapeutiques
NO20053892L (no) Virale polymeraseinhibitorer
NO20092692L (no) MAPK/ERK kinaseinhibitorer
NO20082209L (no) Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer
WO2005074642A3 (fr) Composes chimiques
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NO20065178L (no) Tienopyridinderivater
NO20082145L (no) Prolinamidderivater som natriumkanalmodulatorer
EP2205088A4 (fr) Inhibiteurs à base de naphtalène de protéines anti-apoptotiques
NO20075706L (no) Pyrrolopyridinbaserte inhibitorer av dipeptidylpeptidase IV og metoder
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
CY1109740T1 (el) Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ
AR051754A1 (es) Metodos para preparar compuestos de indazol
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
NO20070564L (no) Kinoliner uten tiazolinonsubstituenter.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application